Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Details for Australian Patent Application No. 2002326529 (hide)

International Classifications

Event Publications

23 January 2003 Complete Application Filed

Priority application(s): 60/309,791 06.08.01 US; 10/000,000 01.08.02 US

19 June 2003 Application Open to Public Inspection

Published as AU-A-2002326529

3 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

9 July 2009 Amendment Made

The nature of the amendment is: Amend the priority details to from 10/000,000 01 Aug 2002 US and 60/309,791 06 Aug 2001 US to read 10/208,817 01 Aug 2002 US and 60/309,791 06 Aug 2001 US 2002342108 InnoMed Technologies, Inc. The nature of the amendment is: Amend the name of the inventor to add Wood, Thomas

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.